Skip to content

Clinical Research on Exosome Signature Biomarkers for Auxiliary Diagnosis and Prognosis Monitoring of Pancreatic Diseases

Clinical Research on Exosome Signature Biomarkers for Auxiliary Diagnosis and Prognosis Monitoring of Pancreatic Diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125519
Enrollment
Unknown
Registered
2026-05-27
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer, acute pancreatitis, chronic pancreatitis, and common benign pancreatic space-occupying lesions (e.g., pancreatic cysts).

Interventions

Healthy control:None.
Benign pancreatic diseases:None

Sponsors

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Age between 20 and 90 years; 2.Pancreatic cancer patients: individuals diagnosed with pancreatic cancer at our institution based on histopathology or imaging findings; 3.Patients with benign pancreatic diseases: including acute pancreatitis, chronic pancreatitis, and common benign pancreatic space-occupying lesions (e.g., pancreatic cysts).

Exclusion criteria

Exclusion criteria: 1.Patients initially enrolled in the benign disease group who are diagnosed with pancreatic cancer during the study period; 2.Individuals with a prior history of malignancy.

Design outcomes

Primary

MeasureTime frame
Exosomal Biomarker;

Countries

China

Contacts

Public ContactJiexin Zhang

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

jiexinzhang@njmu.edu.cn+86 25 6830 3458

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026